NASDAQ: ATHA
Athira Pharma Revenue

Athira Pharma revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ATHA annual revenue was $0.0, with N/A growth year-over-year.

ATHA revenue history

Current Revenue
$0.0
Current Earnings
-$96.9M
Current Profit Margin
0%

Be the first to know when ATHA announces revenue.

ATHA Revenue History By Year

ATHA Yearly RevenueATHA RevenueATHA ChangeATHA Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Athira Pharma Revenue FAQ

What was ATHA's revenue last quarter?

On Invalid Date, Athira Pharma (NASDAQ: ATHA) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Athira Pharma's revenue was $0.00.

What was Athira Pharma's revenue in 2024?

Athira Pharma's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Athira Pharma make in a day?

Based on Athira Pharma annual revenue for the past five years, ATHA makes an average of $0.00 per day.

What was Athira Pharma's annual revenue growth in the past year?

As of Q2 2025, Athira Pharma's revenue has grown null year over year. Athira Pharma's revenue in the past year totaled $0.00.

How much does Athira Pharma make in a year?

Athira Pharma's revenue by year for the past five years is:
  • Athira Pharma's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Athira Pharma's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Athira Pharma's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Athira Pharma's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Athira Pharma's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.